BVF INC/IL Diversified Active

CIK: 0001056807 · Show all filings

Period: Q4 2017 (← Previous) (Next →)

Filing Date: Feb 14, 2018

Total Value ($000): $829,549 (99.6% shares, 0.4% debt)

Holdings (43)

— ARRAY BIOPHARMA INC 13.4%

Value ($000) $111,187 Shares 8,686,498 Est. Cost $8.39 Unrealized —

ANAB ANAPTYSBIO INC 7.2%

Value ($000) $59,868 Shares 594,397 Est. Cost $23.32 Unrealized +215.7%

— BLUEPRINT MEDICINES CORP 7.0%

Value ($000) $57,866 Shares 767,354 Est. Cost $25.16 Unrealized —

XOMA XOMA CORP DEL 6.4%

Value ($000) $53,500 Shares 1,502,800 Est. Cost $5.35 Unrealized +406.5%

— CONCERT PHARMACEUTICALS INC 6.1%

Value ($000) $50,958 Shares 1,969,789 Est. Cost $14.18 Unrealized —

CYTK CYTOKINETICS INC 5.6%

Value ($000) $46,633 Shares 5,721,888 Est. Cost $10.41 Unrealized +9.0%

— CHEMOCENTRYX INC 5.4%

Value ($000) $45,145 Shares 7,587,416 Est. Cost $8.94 Unrealized —

— BIOLINERX LTD 3.4%

Value ($000) $28,335 Shares 25,995,575 Est. Cost $1.01 Unrealized —

SNDX SYNDAX PHARMACEUTICALS INC 3.4%

Value ($000) $28,326 Shares 3,233,618 Est. Cost $9.90 Unrealized 0.0%

— ARQULE INC 3.3%

Value ($000) $27,121 Shares 16,436,912 Est. Cost $1.75 Unrealized —

CTMX CYTOMX THERAPEUTICS INC 2.9%

Value ($000) $23,738 Shares 1,124,483 Est. Cost $14.24 Unrealized +45.6%

— CTI BIOPHARMA CORP 2.8%

Value ($000) $23,038 Shares 8,596,357 Est. Cost $3.77 Unrealized —

KURA KURA ONCOLOGY INC 2.5%

Value ($000) $20,714 Shares 1,353,846 Est. Cost $9.39 Unrealized +57.0%

INFIQ INFINITY PHARMACEUTICALS INC 2.4%

Value ($000) $19,826 Shares 9,766,508 Est. Cost $3.23 Unrealized -35.8%

— PIERIS PHARMACEUTICALS INC 2.4%

Value ($000) $19,808 Shares 2,623,562 Est. Cost $3.18 Unrealized —

— ONCOMED PHARMACEUTICALS INC 2.1%

Value ($000) $17,512 Shares 4,271,289 Est. Cost $8.77 Unrealized —

— REGULUS THERAPEUTICS INC 1.8%

Value ($000) $14,533 Shares 13,974,249 Est. Cost $1.20 Unrealized —

— GTX INC DEL 1.7%

Value ($000) $14,075 Shares 1,107,433 Est. Cost $5.28 Unrealized —

— ERYTECH PHARMA 1.7%

Value ($000) $13,763 Shares 625,000 Est. Cost $22.02 Unrealized —

— VBI VACCINES INC 1.6%

Value ($000) $13,237 Shares 3,100,000 Est. Cost $4.27 Unrealized —

— FORWARD PHARMA A/S 1.5%

Value ($000) $12,646 Shares 3,455,117 Est. Cost $10.61 Unrealized —

SPRO SPERO THERAPEUTICS INC 1.5%

Value ($000) $12,093 Shares 1,029,185 Est. Cost $12.27 Unrealized 0.0%

— CASCADIAN THERAPEUTICS INC 1.4%

Value ($000) $11,593 Shares 3,133,224 Est. Cost $4.31 Unrealized —

— SPRING BK PHARMACEUTICALS INC 1.3%

Value ($000) $11,076 Shares 823,474 Est. Cost $13.67 Unrealized —

XENE XENON PHARMACEUTICALS INC 1.2%

Value ($000) $10,138 Shares 3,588,830 Est. Cost $8.35 Unrealized -67.4%

— GLYCOMIMETICS INC 1.0%

Value ($000) $8,353 Shares 497,474 Est. Cost $7.84 Unrealized —

— ALPINE IMMUNE SCIENCES INC 0.9%

Value ($000) $7,569 Shares 675,759 Est. Cost $11.60 Unrealized —

— SUNESIS PHARMACEUTICALS INC 0.9%

Value ($000) $7,539 Shares 2,043,196 Est. Cost $3.60 Unrealized —

— MOLECULAR TEMPLATES INC 0.9%

Value ($000) $7,256 Shares 724,132 Est. Cost $6.97 Unrealized —

— VERASTEM INC 0.8%

Value ($000) $6,908 Shares 2,250,000 Est. Cost $3.07 Unrealized —

PTGX PROTAGONIST THERAPEUTICS INC 0.7%

Value ($000) $6,118 Shares 294,117 Est. Cost $17.74 Unrealized 0.0%

— IMMUNE DESIGN CORP 0.7%

Value ($000) $5,732 Shares 1,469,800 Est. Cost $3.90 Unrealized —

— TOCAGEN INC 0.7%

Value ($000) $5,706 Shares 556,683 Est. Cost $12.03 Unrealized —

CRVS CORVUS PHARMACEUTICALS INC 0.6%

Value ($000) $4,759 Shares 459,396 Est. Cost $11.95 Unrealized +7.2%

— ACHILLION PHARMACEUTICALS INC 0.6%

Value ($000) $4,632 Shares 1,608,433 Est. Cost $2.88 Unrealized —

— INTRA CELLULAR THERAPIES INC 0.5%

Value ($000) $3,958 Shares 273,350 Est. Cost $15.78 Unrealized —

— OREXIGEN THERAPEUTICS INC 0.4%

Value ($000) $3,550 Shares 10,000,000 Est. Cost $0.27 Unrealized —

— CONTRAFECT CORP 0.4%

Value ($000) $3,535 Shares 3,500,000 Est. Cost $1.11 Unrealized —

— VICAL INC 0.3%

Value ($000) $2,579 Shares 1,409,444 Est. Cost $1.83 Unrealized —

ANTH ANTHERA PHARMACEUTICALS INC 0.2%

Value ($000) $2,007 Shares 1,216,403 Est. Cost $2.15 Unrealized -20.0%

— PAIN THERAPEUTICS INC 0.2%

Value ($000) $1,302 Shares 325,509 Est. Cost $4.12 Unrealized —

— OREXIGEN THERAPEUTICS INC 0.1%

Value ($000) $948 Shares 734,976 Est. Cost $3.32 Unrealized —

— LOXO ONCOLOGY INC 0.0%

Value ($000) $369 Shares 4,386 Est. Cost $53.87 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ARRAY BIOPHARMA INC	8,686,498	$111,187	13.4%	$8.39	—	COM	04269X105
ANAB	ANAPTYSBIO INC	594,397	$59,868	7.2%	$23.32	+215.7%	COM	032724106
—	BLUEPRINT MEDICINES CORP	767,354	$57,866	7.0%	$25.16	—	COM	09627Y109
XOMA	XOMA CORP DEL	1,502,800	$53,500	6.4%	$5.35	+406.5%	COM NEW	98419J206
—	CONCERT PHARMACEUTICALS INC	1,969,789	$50,958	6.1%	$14.18	—	COM	206022105
CYTK	CYTOKINETICS INC	5,721,888	$46,633	5.6%	$10.41	+9.0%	COM NEW	23282W605
—	CHEMOCENTRYX INC	7,587,416	$45,145	5.4%	$8.94	—	COM	16383L106
—	BIOLINERX LTD	25,995,575	$28,335	3.4%	$1.01	—	SPONSORED ADR	09071M106
SNDX	SYNDAX PHARMACEUTICALS INC	3,233,618	$28,326	3.4%	$9.90	0.0%	COM	87164F105
—	ARQULE INC	16,436,912	$27,121	3.3%	$1.75	—	COM	04269E107
CTMX	CYTOMX THERAPEUTICS INC	1,124,483	$23,738	2.9%	$14.24	+45.6%	COM	23284F105
—	CTI BIOPHARMA CORP	8,596,357	$23,038	2.8%	$3.77	—	COM NEW	12648L601
KURA	KURA ONCOLOGY INC	1,353,846	$20,714	2.5%	$9.39	+57.0%	COM	50127T109
INFIQ	INFINITY PHARMACEUTICALS INC	9,766,508	$19,826	2.4%	$3.23	-35.8%	COM	45665G303
—	PIERIS PHARMACEUTICALS INC	2,623,562	$19,808	2.4%	$3.18	—	COM	720795103
—	ONCOMED PHARMACEUTICALS INC	4,271,289	$17,512	2.1%	$8.77	—	COM	68234X102
—	REGULUS THERAPEUTICS INC	13,974,249	$14,533	1.8%	$1.20	—	COM	75915K101
—	GTX INC DEL	1,107,433	$14,075	1.7%	$5.28	—	COM NEW	40052B207
—	ERYTECH PHARMA	625,000	$13,763	1.7%	$22.02	—	SPONSORED ADR	29604W108
—	VBI VACCINES INC	3,100,000	$13,237	1.6%	$4.27	—	COM NEW	91822J103
—	FORWARD PHARMA A/S	3,455,117	$12,646	1.5%	$10.61	—	SPONSORED ADR	34986J105
SPRO	SPERO THERAPEUTICS INC	1,029,185	$12,093	1.5%	$12.27	0.0%	COM	84833T103
—	CASCADIAN THERAPEUTICS INC	3,133,224	$11,593	1.4%	$4.31	—	COM NEW	14740B606
—	SPRING BK PHARMACEUTICALS INC	823,474	$11,076	1.3%	$13.67	—	COM	849431101
XENE	XENON PHARMACEUTICALS INC	3,588,830	$10,138	1.2%	$8.35	-67.4%	COM	98420N105
—	GLYCOMIMETICS INC	497,474	$8,353	1.0%	$7.84	—	COM	38000Q102
—	ALPINE IMMUNE SCIENCES INC	675,759	$7,569	0.9%	$11.60	—	COM	02083G100
—	SUNESIS PHARMACEUTICALS INC	2,043,196	$7,539	0.9%	$3.60	—	COM PAR	867328700
—	MOLECULAR TEMPLATES INC	724,132	$7,256	0.9%	$6.97	—	COM	608550109
—	VERASTEM INC	2,250,000	$6,908	0.8%	$3.07	—	COM	92337C104
PTGX	PROTAGONIST THERAPEUTICS INC	294,117	$6,118	0.7%	$17.74	0.0%	COM	74366E102
—	IMMUNE DESIGN CORP	1,469,800	$5,732	0.7%	$3.90	—	COM	45252L103
—	TOCAGEN INC	556,683	$5,706	0.7%	$12.03	—	COM	888846102
CRVS	CORVUS PHARMACEUTICALS INC	459,396	$4,759	0.6%	$11.95	+7.2%	COM	221015100
—	ACHILLION PHARMACEUTICALS INC	1,608,433	$4,632	0.6%	$2.88	—	COM	00448Q201
—	INTRA CELLULAR THERAPIES INC	273,350	$3,958	0.5%	$15.78	—	COM	46116X101
—	OREXIGEN THERAPEUTICS INC	10,000,000	$3,550	0.4%	$0.27	—	NOTE 2.750%12/0	686164AB0
—	CONTRAFECT CORP	3,500,000	$3,535	0.4%	$1.11	—	COM	212326102
—	VICAL INC	1,409,444	$2,579	0.3%	$1.83	—	COM NEW	925602203
ANTH	ANTHERA PHARMACEUTICALS INC	1,216,403	$2,007	0.2%	$2.15	-20.0%	COM	03674U300
—	PAIN THERAPEUTICS INC	325,509	$1,302	0.2%	$4.12	—	COM NEW	69562K506
—	OREXIGEN THERAPEUTICS INC	734,976	$948	0.1%	$3.32	—	COM NEW	686164302
—	LOXO ONCOLOGY INC	4,386	$369	0.0%	$53.87	—	COM	548862101